These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21527209)

  • 1. The PE and PPE proteins of Mycobacterium tuberculosis.
    Mukhopadhyay S; Balaji KN
    Tuberculosis (Edinb); 2011 Sep; 91(5):441-7. PubMed ID: 21527209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of Mycobacterium tuberculosis PE/PPE genes: a molecular switch to virulence?
    Mohareer K; Tundup S; Hasnain SE
    J Mol Microbiol Biotechnol; 2011; 21(3-4):97-109. PubMed ID: 22286037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory functions and expression patterns of PE/PPE family members: Roles in pathogenicity and impact on anti-tuberculosis vaccine and drug design.
    Ahmed A; Das A; Mukhopadhyay S
    IUBMB Life; 2015 Jun; 67(6):414-27. PubMed ID: 26104967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential.
    Chaitra MG; Hariharaputran S; Chandra NR; Shaila MS; Nayak R
    Vaccine; 2005 Jan; 23(10):1265-72. PubMed ID: 15652669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design.
    Gastelum-Aviña P; Velazquez C; Espitia C; Lares-Villa F; Garibay-Escobar A
    Expert Rev Vaccines; 2015 May; 14(5):699-711. PubMed ID: 25693607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
    Sable SB; Plikaytis BB; Shinnick TM
    Vaccine; 2007 Feb; 25(9):1553-66. PubMed ID: 17166640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccines against tuberculosis.
    Tyagi AK; Nangpal P; Satchidanandam V
    Tuberculosis (Edinb); 2011 Sep; 91(5):469-78. PubMed ID: 21334259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune responses to M. tuberculosis infection.
    Natarajan K; Kundu M; Sharma P; Basu J
    Tuberculosis (Edinb); 2011 Sep; 91(5):427-31. PubMed ID: 21550855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PE_PGRS: Vital proteins in promoting mycobacterial survival and modulating host immunity and metabolism.
    Xie Y; Zhou Y; Liu S; Zhang XL
    Cell Microbiol; 2021 Mar; 23(3):e13290. PubMed ID: 33217152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.
    Mustafa AS
    Tuberculosis (Edinb); 2005; 85(5-6):367-76. PubMed ID: 16253561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the Mycobacterium tuberculosis PE/PPE genes.
    Voskuil MI; Schnappinger D; Rutherford R; Liu Y; Schoolnik GK
    Tuberculosis (Edinb); 2004; 84(3-4):256-62. PubMed ID: 15207495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
    Chaitra MG; Nayak R; Shaila MS
    Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the mycobacterial PE and PPE proteins provide a framework for future research.
    Ates LS
    Mol Microbiol; 2020 Jan; 113(1):4-21. PubMed ID: 31661176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-A*0201-restricted cytotoxic T-cell epitopes in three PE/PPE family proteins of Mycobacterium tuberculosis.
    Chaitra MG; Shaila MS; Chandra NR; Nayak R
    Scand J Immunol; 2008 Apr; 67(4):411-7. PubMed ID: 18248530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Mycobacterium tuberculosis genoma and production of a recombinant protein containing specific B and T cell antigenic determinants--new approaches to second generation antituberculosis vaccines.
    Colizzi V; Vismara D; D'Urso C; Mezzopreti MF; Lombardi G; Piccolella E; Damiani G; Marelli P; Campa M
    Z Erkr Atmungsorgane; 1989; 172(1):40-52. PubMed ID: 2467445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.